Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

0 Calificaciones
0
Episodio
51 of 144
Duración
33min
Idioma
Inglés
Formato
Categoría
Economía y negocios

Private-debt firms are set to consolidate as larger companies dominate deal flow, according to Marc Chowrimootoo, portfolio manager at Hayfin Capital Management. “We’re seeing a concentration within fewer hands,” Chowrimootoo tells Bloomberg News’ Lisa Lee and James Crombie and Bloomberg Intelligence’s Julie Hung in the latest Credit Edge podcast. “That trend is going to continue.” He identifies debt refinancing as the big opportunity for private lenders in 2024. Hayfin likes the health-care and software sectors, while avoiding smaller borrowers that are struggling with higher rates. In addition, BI’s Hung weighs the impact on food and drink companies of weight-loss drugs like Ozempic.

See omnystudio.com/listener for privacy information.


Escucha y lee

Descubre un mundo infinito de historias

  • Lee y escucha todo lo que quieras
  • Más de 1 millón de títulos
  • Títulos exclusivos + Storytel Originals
  • Precio regular: CLP 7,990 al mes
  • Cancela cuando quieras
Suscríbete ahora
Copy of Device Banner Block 894x1036 3
Cover for Hayfin Expects Private-Debt M&A; BI on Ozempic Risks

Otros podcasts que te pueden gustar...